Related Experiment Video
Updated: Aug 11, 2026
09:38
Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Occupational risk factors for Alzheimer disease: a case-control study
R T Gun1, A E Korten, A F Jorm
1Department of Community Medicine, University of Adelaide, Australia.
Alzheimer Disease and Associated Disorders
|March 1, 1997
Summary
This study found no link between occupational exposures like solvents or heavy metals and Alzheimer disease (AD). Research suggests that workplace chemical and physical agents do not cause AD.
Area of Science:
- Occupational health
- Neurodegenerative diseases
- Environmental epidemiology
Background:
- Environmental factors are implicated in Alzheimer disease (AD) etiology.
- The specific role of occupational exposures remains under investigation.
- Understanding occupational risks is crucial for public health and prevention strategies.
Purpose of the Study:
- To investigate the association between occupational chemical and physical exposures and the risk of developing Alzheimer disease (AD).
- To determine if specific workplace agents contribute to AD pathogenesis.
Main Methods:
- A case-control study involving 170 AD patients and 170 matched controls.
- Detailed occupational histories collected from informants for both cases and controls.
- Exposure assessment conducted by blinded occupational hygienists using the Job-Exposure Matrix.
Main Results:
- No statistically significant associations were identified between occupational exposures (e.g., solvents, lead, mercury, asbestos) and AD occurrence.
- This lack of association was consistent across the entire study group and within subgroups with a family history of AD.
Conclusions:
- The study findings do not support an occupational cause for Alzheimer disease (AD).
- Current evidence suggests that common occupational chemical and physical exposures are unlikely to be significant risk factors for AD.
More Related Videos
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...